Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merit Medical Systems (MMSI) EBITDA (2016 - 2025)

Historic EBITDA for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to $42.6 million.

  • Merit Medical Systems' EBITDA rose 1436.09% to $42.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $167.1 million, marking a year-over-year increase of 939.37%. This contributed to the annual value of $155.7 million for FY2024, which is 2561.56% up from last year.
  • Merit Medical Systems' EBITDA amounted to $42.6 million in Q3 2025, which was up 1436.09% from $46.9 million recorded in Q2 2025.
  • Over the past 5 years, Merit Medical Systems' EBITDA peaked at $46.9 million during Q2 2025, and registered a low of $8.9 million during Q2 2021.
  • In the last 5 years, Merit Medical Systems' EBITDA had a median value of $30.4 million in 2022 and averaged $29.4 million.
  • Its EBITDA has fluctuated over the past 5 years, first soared by 2479218.75% in 2021, then skyrocketed by 203.28% in 2025.
  • Over the past 5 years, Merit Medical Systems' EBITDA (Quarter) stood at $21.9 million in 2021, then skyrocketed by 38.92% to $30.4 million in 2022, then rose by 10.5% to $33.6 million in 2023, then increased by 8.78% to $36.6 million in 2024, then grew by 16.54% to $42.6 million in 2025.
  • Its EBITDA was $42.6 million in Q3 2025, compared to $46.9 million in Q2 2025 and $41.0 million in Q1 2025.